Novogene Co., Ltd. 688315.SS Stock
Novogene Co., Ltd. Price Chart
Novogene Co., Ltd. 688315.SS Financial and Trading Overview
| Novogene Co., Ltd. stock price | 12.97 CNY |
| Previous Close | 28.15 CNY |
| Open | 28.05 CNY |
| Bid | 27.98 CNY x N/A |
| Ask | 27.99 CNY x N/A |
| Day's Range | 27.86 - 28.6 CNY |
| 52 Week Range | 19.99 - 41.76 CNY |
| Volume | 902.68K CNY |
| Avg. Volume | 2.55M CNY |
| Market Cap | 11.2B CNY |
| Beta (5Y Monthly) | 0.771801 |
| PE Ratio (TTM) | 60.826084 |
| EPS (TTM) | 0.47 CNY |
| Forward Dividend & Yield | 0.05 (0.16%) |
| Ex-Dividend Date | May 18, 2023 |
| 1y Target Est | 41.88 CNY |
688315.SS Valuation Measures
| Enterprise Value | 10.37B CNY |
| Trailing P/E | 60.826084 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.6564536 |
| Price/Book (mrq) | 5.6422663 |
| Enterprise Value/Revenue | 5.24 |
| Enterprise Value/EBITDA | 33.164 |
Trading Information
Novogene Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.771801 |
| 52-Week Change | 12.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 41.76 CNY |
| 52 Week Low | 19.99 CNY |
| 50-Day Moving Average | 32.82 CNY |
| 200-Day Moving Average | 29.94 CNY |
688315.SS Share Statistics
| Avg. Volume (3 month) | 2.55M CNY |
| Avg. Daily Volume (10-Days) | 1.92M CNY |
| Shares Outstanding | 400.2M |
| Float | 115.09M |
| Short Ratio | N/A |
| % Held by Insiders | 76.59% |
| % Held by Institutions | 13.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.047 |
| Trailing Annual Dividend Yield | 0.16% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1333 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 9.13% |
| Operating Margin (ttm) | 10.58% |
| Gross Margin | 43.76% |
| EBITDA Margin | 15.80% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | 9.79% |
Income Statement
| Revenue (ttm) | 1.98B CNY |
| Revenue Per Share (ttm) | 4.95 CNY |
| Quarterly Revenue Growth (yoy) | 14.00% |
| Gross Profit (ttm) | 849.07M CNY |
| EBITDA | 312.77M CNY |
| Net Income Avi to Common (ttm) | 180.87M CNY |
| Diluted EPS (ttm) | 0.46 |
| Quarterly Earnings Growth (yoy) | 19.30% |
Balance Sheet
| Total Cash (mrq) | 969.8M CNY |
| Total Cash Per Share (mrq) | 2.42 CNY |
| Total Debt (mrq) | 64.24M CNY |
| Total Debt/Equity (mrq) | 3.22 CNY |
| Current Ratio (mrq) | 2.033 |
| Book Value Per Share (mrq) | 4.959 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 464.78M CNY |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Novogene Co., Ltd.
| Country | China |
| State | N/A |
| City | Beijing |
| Address | Building 301 |
| ZIP | N/A |
| Phone | 86 10 8283 7801 |
| Website | https://www.novogene.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Novogene Co., Ltd. provides genomic services and solutions worldwide. The company offers genomic solutions, such as human genome sequencing, gene regulation, single cell sequencing, animal and plant solutions, and microbial genome sequencing; and cancer genomic profiling, whole exome sequencing, and FFPE RNA sequencing, as well as clinical-grade whole exome sequencing services. It also provides NovoFocus, a next-generation sequencing based companion diagnostic assay for PARP inhibitor therapies; and NovoNeoantigen, a bioinformatics pipeline for the identification of cancer neoantigens with whole exome sequencing and whole transcriptome sequencing data from paired tumor-normal samples. Novogene Co., Ltd. has a strategic partnership with Hummingbird Bioscience Pte. Ltd. to support the development of investigational drug candidate HMBD-001, an anti-HER3 antibody to be evaluated for treatment of various tumor types, including NRG1-fusion driven cancers. The company was founded in 2011 and is headquartered in Beijing, China.
Q&A For Novogene Co., Ltd. Stock
What is a current 688315.SS stock price?
Novogene Co., Ltd. 688315.SS stock price today per share is 12.97 CNY.
How to purchase Novogene Co., Ltd. stock?
You can buy 688315.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novogene Co., Ltd.?
The stock symbol or ticker of Novogene Co., Ltd. is 688315.SS.
Which industry does the Novogene Co., Ltd. company belong to?
The Novogene Co., Ltd. industry is Biotechnology.
How many shares does Novogene Co., Ltd. have in circulation?
The max supply of Novogene Co., Ltd. shares is 416.2M.
What is Novogene Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Novogene Co., Ltd. PE Ratio is 27.59574500 now.
What was Novogene Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Novogene Co., Ltd. EPS is 0.47 CNY over the trailing 12 months.
Which sector does the Novogene Co., Ltd. company belong to?
The Novogene Co., Ltd. sector is Healthcare.